Vimarsana
Biggest News Aggregation in the World

Page 35 - Stem Cell Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stem Cell Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stem Cell Therapy Today - Breaking & Trending Today

Stem Cell Transplants for Early MS: Who Benefits Most? - Vimarsana News

Stem Cell Transplants for Early MS: Who Benefits Most?

Researchers are exploring HSCT as a rescue therapy in early-stage MS. But there's no consensus on best practices.

FDA OKs Ivosidenib for IDH1-mutated Myelodysplastic Syndromes - Vimarsana News

FDA OKs Ivosidenib for IDH1-mutated Myelodysplastic Syndromes

The FDA approval was based on a small study, in which 38.9% of patients with relapsed or refractory disease went into complete remission.

Sarilumab Demonstrates Sustained Remission in Patients with Polymyalgia Rheumatica - Vimarsana News

Sarilumab Demonstrates Sustained Remission in Patients with Polymyalgia Rheumatica

At week 52, sustained remission was observed in significantly more patients receiving sarilumab compared with placebo.

Source: ajmc.com
Survival on the Upswing in Multiple Myeloma - Vimarsana News

Survival on the Upswing in Multiple Myeloma

Hematologists are heralding a new era in multiple myeloma. Experts discuss how times have changed.

Salvage Option to Replace Transplant in RR Hodgkin Lymphoma? - Vimarsana News

Salvage Option to Replace Transplant in RR Hodgkin Lymphoma?

A chemoimmunotherapy and radiation combination without autologous stem cell transplant produced high response rates in children and young adults with low-risk relapsed/refractory Hodgkin lymphoma.